TEMERITDUO 5 mg/12.5 mg, film-coated tablet 90 tablets
Active ingredients: (S,R,R,R)-nebivolol hydrochloride, HYDROCHLOROTHIAZIDE, Nebivolol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TEMERITDUO 5 mg/12,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polypropylène polycyclooléfine aluminium de 90 comprimé(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63995388CIP74900432CIP133400949004324Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 12,5 mg · un comprimé | SA |
| CHLORHYDRATE DE NÉBIVOLOLcomprimé | — | SA |
| NÉBIVOLOL BASEcomprimé | 5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.